4//SEC Filing
DeWitt Todd M 4
Accession 0001181431-12-038056
CIK 0001002811other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 6:52 PM ET
Size
16.1 KB
Accession
0001181431-12-038056
Insider Transaction Report
Form 4
KENSEY NASH CORPKNSY
DeWitt Todd M
VP of Biomaterials
Transactions
- Disposition to Issuer
Stock Appreciation Right
2012-06-22$12.86/sh−10,000$128,600→ 0 totalExercise: $25.64Exp: 2018-09-20→ Common Stock (10,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2012-06-22$4.14/sh−14,000$57,960→ 0 totalExercise: $34.36Exp: 2014-06-28→ Common Stock (14,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2012-06-22$9.52/sh−10,600$100,912→ 0 totalExercise: $28.98Exp: 2020-09-20→ Common Stock (10,600 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2012-06-22$6.22/sh−7,000$43,540→ 0 totalExercise: $32.28Exp: 2018-09-22→ Common Stock (7,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2012-06-22$10.48/sh−7,000$73,360→ 0 totalExercise: $28.02Exp: 2017-10-23→ Common Stock (7,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2012-06-22$10.02/sh−10,000$100,200→ 0 totalExercise: $28.48Exp: 2019-09-22→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]This stock appreciation right was cancelled pursuant to the merger contemplated by the Agreement and Plan of Merger, dated as of May 2, 2012 (the "Merger Agreement"), among Koninklijke DSM N.V., Merger Sub and Kensey Nash Corporation (the "Company"), in exchange for a cash payment equal to the product of (A) the excess of the $38.50 consideration payable in the merger for each share of the Company's common stock over the base price per share of such stock appreciation right, multiplied by (B) the number of shares of the Company's common stock subject to such stock appreciation right.
- [F2]This option was cancelled pursuant to the merger contemplated by the Merger Agreement in exchange for a cash payment equal to the product of (A) the excess of the $38.50 consideration payable in the merger for each share of the Company's common stock over the exercise price per share of the option, multiplied by (B) the number of shares of the Company's common stock subject to such option.
Documents
Issuer
KENSEY NASH CORP
CIK 0001002811
Entity typeother
Related Parties
1- filerCIK 0001441287
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 6:52 PM ET
- Size
- 16.1 KB